Introduction
The administration of high-dose radio/chemotherapy followed by autologous hematopoietic transplantation constitutes the therapy of choice for acute myelocytic leukemia (AML) patients lacking a compatible donor. 1 However, an increased risk of relapse has been observed in these patients when compared to patients transplanted with allogeneic grafts. Differences on the generation of a graft-versus-leukemia (GVL) effect may certainly account for the differential response of these recipients. 2 Nevertheless, results based on the gene marking of hematopoietic samples have also revealed the contribution of the autograft on leukemia relapse, thus indicating the necessity of increasing the efficacy of current procedures of graft purging. 3 In this respect, the improvement of models mimicking the relapse of patients transplanted with leukemiaCorrespondence: JA Bueren; Fax: 34-91/346 63 93 Received 11 June 1999; accepted 16 November 1999 contaminated grafts constitutes a basic tool for developing more efficient protocols of graft purging.
In order to facilitate the identification of syngenic leukemia cells in hematopoietic grafts or in transplanted recipients, marker genes such as the bacterial phosphotransferase neomicine (neo r ) gene have been transferred into the leukemic population. This allowed the identification of leukemic cells by means of RNA in situ hybridization. 4 More recently, genes encoding intracellular enzymes, ie the Escherichia coli lac Z gene have also been used as leukemia cell markers in order to identify the marked cells using simpler techniques. [5] [6] [7] The generation of new marker genes, like those encoding cell-surface antigens, 8, 9 now facilitates the follow-up and also the separation of the marked population using routine antibody staining techniques. These procedures are simple, rapid and do not require cellular fixation of the sample. Moreover, in contrast to the significant endogenous background frequently observed in samples stained with chromogenic or fluorescent substrates, a very low background staining is characteristic of ectopic antigen determinations. 10, 11 This latter aspect is of crucial importance for studies in which limiting numbers of marked cells are investigated.
As previously shown, the myelomonocytic WEHI-3B cells used in this study 12 constitute an adequate model for developing new purging strategies based on differentiation therapy, 13 and more recently immunotherapy 14 and gene therapy. 15 In this work, WEHI-3B cells have been stably transduced with a retroviral vector encoding the low-affinity human nerve growth factor receptor (NGFr). This transgene has been previously used in experimental 8, 16, 17 and clinical studies, 18 and revealed remarkable properties as a cell marker gene. Aiming to mimic the relapse of patients transplanted with leukemia-contaminated grafts, Balb/c BM cells were contaminated with decreasing numbers of NGFr-marked WEHI-3B cells (originally derived from Balb/c mice) and then infused into lethally irradiated syngenic mice. FACS analysis of the NGFr marker facilitated the rapid and accurate determination of leukemia cells in the transplanted graft as well as in the recipient tissues. To our knowledge, our approach constitutes the first experimental model of leukemia relapse mediated by the transplantation of BM grafts contaminated with genemarked leukemia cells. The proposed model may constitute an improved tool for studies aiming to optimize current procedures of hematopoietic graft purging.
Leukemia

Materials and methods
Animals
Eight-to 10 week-old BALB/c ByJ mice were used. Breeding pairs were originally obtained from Jackson Laboratory (Bar Harbor, ME, USA) and bred at the CIEMAT Animal Facility (Registration number 28079-21A). Mice were maintained under high standards conditions (HEPA filtered air, regulated temperature of 22°C, light/dark cycle of 12 h, and allowed food and UV irradiated water ad libitum) and routinely screened for pathogens, in accordance with FELASA (Federation of European Laboratory Animal Science Associations) procedures. All the experiments were conducted according to the Spanish regulation (RD 233/88, Ministry of Agriculture, Food and Fisheries) about the use and treatment of experimental animals.
Cell culture
WEHI-3B D
+ leukemia cells were obtained from ECACC (Salisbury, UK) and maintained in suspension cultures with RPMI 1640 medium (Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco), L-glutamine (2 mM) and antibiotics (penicillin 100 units/ml and streptomycin 50 g/ml). In some experiments WEHI-3B cells were grown in semisolid media. In these cases, cells suspensions were mixed with Bactoagar (0.3% final concentration; Difco laboratories, Detroit, Ml, USA), seeded in 35 mm plastic culture dishes (Nunc, Roskilde, Denmark), and cultured for 7 days. 3T3 cells and AM12/LNSN packaging cells were maintained in DMEM medium supplemented with 10% FBS, L-glutamine and antibiotics. All cultures were grown at 37°C, in a 95% humidified atmosphere with 5% CO 2 .
Retroviral vector and WEHI-3B transduction
The LNSN vector harbors the low affinity human nerve growth factor receptor (NGFr) and the phosphotransferase neomicine (neo r ) genes driven by the MoMuLV-LTR and the SV40 promoters, respectively. To infect WEHI-3B cells, exponentially growing samples were incubated for 6 h at 37°C with infective supernatants generated by a AM12 clone producing high titers of the vector (kind gift of Drs M Grez and H Knoess, GeorgSpeyer-Haus, Frankfurt, Germany) in the presence of 8 g/ml polybrene. After infection, cells were seeded in semisolid media containing 500 g/ml G-418 (active product). G-418-resistant colonies were isolated, expanded in liquid culture medium and tested for NGFr expression.
In vivo studies
Bone marrow cells from Balb/c mice were resuspended in Iscove's modified Dulbecco's medium (IMDM; Gibco) and mixed with graded numbers of parental or transduced WEHI-3B cells maintained under exponential growth. Aliquots of 0.2 ml were injected intravenously into irradiated Balb/c recipients (mice were irradiated with two doses of 4.5 Gy spaced 4 h apart, using a Philips MG324 X-ray equipment, at 300 kV, 12.8 mA; dose rate: 1.03 Gy/min, Philips, Hamburg, Germany). At different times post-transplantation mice were killed and hematopoietic and non-hematopoietic tissues were obtained for evaluation of tumor infiltration.
FACS analysis
FACS analyses were made in a Coulter EPICS Elite ESP apparatus (Coulter, Hialeah, FL, USA). After washing in PBA (phosphate-buffered saline containing 0.1% (w/v) bovine serum albumin and 0.02% (w/v) sodium azide), cells were incubated in 50 l with standard concentrations of FITC-conjugated mouse anti-NGFr monoclonal antibody (Boehringer Mannheim, Mannheim, Germany) at 4°C for 30 min, washed again and analyzed. To exclude dead cells, propidium iodide (1 g/ml) was added to the samples before analysis. Typically 10 000 viable cells were collected. Offline analysis was done by using the WinMDI free software package (a kind gift of Dr J Trotter, The Scripps Research Institute, La Jolla, CA, USA).
DNA analysis
DNA was extracted using the proteinase K/sodium dodecyl sulfate method from 10 7 cells, DNA was phenol-extracted and Leukemia ethanol-precipitated, essentially as previously described. 19 Ten micrograms of genomic DNA were digested with the indicated restriction enzymes, electrophoresed on 0.8% agarose gels and transferred on to Gene Screen Plus nylon membranes (Dupont NEN Research Products, Boston, MA, USA) using the alkaline method for DNA. Integrated LNSN retroviral sequences were developed by hybridization of blots with a 1200 bp fragment of the neo r gene labeled with ␣-32 P-dCTP by random priming. Membranes were pre-hybridized, hybridized, washed and exposed to X-ray films. 20 In some experiments DNA samples were analyzed by dot-blot hybridization, using the probe described for Southern analysis, under conditions previously described. 21 
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Statistics
Data are presented as the mean ± standard error of the mean. The significance of differences between groups was determined by using the two-tailed Student's t-test. The processing and statistical analyses of the data were performed by using the software Stata Statistical Software: Release 5.0 (Stata Corporation, College Station, TX, USA).
Results
Generation of WEHI-3B clones genetically marked with the NGFr transgene
WEHI-3B clones positive for NGFr expression were generated by means of the incubation of exponentially growing WEHI-3B cells with LNSN supernatants, followed by the culture in semisolid media in the presence of 0.5 mg/ml G-418 (see Materials and methods). Twenty-four clones were then picked up from the agar plates and expanded in liquid culture medium. As observed in representative clones shown in Figure 1 , a wide expression pattern of the NGFr transgene was obtained in the G-418 selected clones. Clones expressing the highest and more homogeneous levels of the NGFr transgene (clones 8 and 9) were selected for further studies.
Aiming to investigate the stability of expression of the NGFr transgene in these two clones, cells were maintained in in vitro exponential growth for up to 4 months. Figure 2 shows that after 15 and 45 passages of clone 8, 99.2% and 82.5% of the cells still expressed high levels of the transgene. In the case of clone 9, similar results were obtained.
In vitro cell growth properties of WEHI-3B/NGFr transduced clones
To investigate whether the growth of the transduced cells was modified as a result of the gene transfer process, the in vitro growth kinetics of parental WEHI-3B and WEHI-3B/NGFr cells (clones 8 and 9) were compared. As shown in Figure 3a and b, similar doubling times and cloning efficiencies in agar medium were observed for these clones. To evaluate whether the sensitivity of WEHI-3B cells to drugs conventionally used for the positive or negative selection of genetically modified cells was changed as a result of the gene transfer process, cells were grown in agar medium containing increasing concentrations of puromicine and gancyclovir. As deduced from the survival curves shown in Figure 3c and d, in neither case were evident changes in the behavior of the transduced clones observed when compared to the parental cell line.
Genetic characterization of WEHI-3B/NGFr clone 8
Although both clone 8 and clone 9 gave good results in terms of transgene expression and cell growth, only one of these two clones (clone 8) was pre-selected for the subsequent studies. To determine whether genetic rearrangements had been introduced in the viral genome during the insertion of the provirus, genomic DNA of WEHI-3B/NGFr-8 cells was purified and digested with enzymes cleaving the LTRs of the provirus (SacI and XbaI). In addition, to determine the number of provirus inserts, DNA was digested with BglII, which does not cleave the provirus DNA (Figure 4a) . As a control of provirus copy number, DNA from the 3T3-neo r cell line, transduced with a single copy of the PXT1 retroviral vector, 21 was included. The hybridization of genomic DNA samples with a probe for the neo r gene (Figure 4b ) revealed the presence of a band with the expected size in WEHI-3B/NGFr DNA digested with SacI and XbaI enzymes, indicating that no rearrangements had been introduced in the provirus. On the other hand, the presence of a single band in the sample digested with BglII clearly indicated that only one provirus had been integrated into this cell clone.
Accurate determination by FACS analysis of leukemia contamination in bone marrow samples
To investigate whether the presence of WEHI-3B/NGFr cells in contaminated BM samples could be detected by FACS analysis in a quantitative manner, BM cells from Balb/c mice were mixed with graded numbers of WEHI-3B/NGFr-8 cells and then stained with anti-NGFr antibodies and analyzed by flow cytometry. Figure 5a shows the FACS histogram analysis of contaminated BM samples, revealing the unambiguous identification of the leukemia-marked cells. The analysis of the relationship between the actual values of leukemia contamination and the experimental data deduced from the FACS analysis evidenced a linear correlation (r 2 = 0.999) between both parameters (see Figure 5b ). As deduced from these results, it can be concluded that the contamination of mouse BM with syngenic WEHI-3B/NGFr cells can be accurately determined by means of flow cytometry analysis.
In vivo model of autograft-mediated relapse based on the transplantation of syngenic bone marrow contaminated with genetically marked WEHI-3B/NGFr cells
Previous studies have shown that either WEHI-3B 4,5 or WEHI-3B/NGFr cells (data not shown) are capable of generating leukemia in non-conditioned syngenic Balb/c recipients. With the aim of modelling the relapse of patients transplanted with leukemia-contaminated grafts, in the current experiments Balb/c mice were lethally irradiated and then transplanted with BM contaminated with graded numbers of syngenic WEHI-3B and WEHI-3B/NGFr-8 cells. While irradiated untransplanted mice died within about 14 days postirradiation, the infusion of either 2 × 10 6 or 10 5 syngenic BM cells rescued all animals from the myelosuppressive conditioning (not shown).
The survival curves of mice transplanted with grafts consisting of 2 × 10 6 BM cells contaminated with parental WEHILeukemia 3B cells or WEHI-3B/NGFr-8 cells is shown in Figure 6a and b, respectively. From these figures it is first deduced that similar leukemia dose-dependent survival curves are observed in recipients transplanted with the parental and the transduced cells. While the infusion of grafts contaminated with 100 leukemia cells did not result in the recipient's mortality, samples contaminated with 1000 parental and WEHI-3B/NGFr-8 cells killed 80% and 67% of recipients, respectively, at 100 days post-transplantation (data not significantly different in log-rank analysis). The transplantation of higher numbers, 10 4 or 10 5 leukemia cells, killed all recipients within the first 2 months post-transplantation.
To determine whether the death of the animals was a consequence of absolute number of inoculated leukemic cells, or on the other hand, whether it was mediated by the repopulating competition between the BM and the leukemic cells, further groups of recipients were transplanted as above, although in this case only 10 5 BM cells were used as the hematopoietic graft. As shown in Figure 6c , the Kaplan-Meier analysis of these data was very similar to that found in Figure  6b . In both instances, the log-rank test evidenced a significant difference between groups inoculated with 10 2 leukemia cells, with respect to mice infused with 10 3 leukemia cells, and also between this group with respect to groups infused with 10 4 or 10 5 leukemia cells (P Ͻ 0.001). Significantly, this test revealed that the survival rate of the animals was strictly dependent on the total number of infused leukemia cells, regardless of the number of transplanted BM cells (2 × 10 6 or 10 5 BM cells per mouse). 
Identification of leukemia cells in recipient mice
In order to identify the transduced leukemia cells in the tissues of recipient mice, animals were killed at different times posttransplantation or when evidence of hind limb paralysis was noted. Samples from different organs were collected and analyzed by flow cytometry. A large proportion of NGFr + cells was observed in the BM and liver of all animals inoculated with at least 1000 leukemia cells. The presence of the leukemic cells in these organs was well identified by peaks that did not overlap either with signals observed in isotype controls or in samples from non-leukemic mice. Leukemia cells were also observed, although in a limited proportion in the spleen and in some instances in the lung, kidney and peripheral blood (see Figure 7 ). These observations were consistent with dot-blot analyses in which DNA from these tissues were hybridized with a probe for the neo r gene (not shown), indicating that the flow cytometry determination of the NGFr marker can be used as a reliable indicator of leukemia dissemination in tissues from recipient mice.
In the last set of experiments, PB determinations were made in irradiated recipients, 20 days after transplantation of 2 × 10 6 BM cells contaminated with a graded number of leukemia cells. As shown in Figure 8 , an evident increase in the number of PB leukocytes was associated with the transplantation of increasing numbers of WEHI-3B cells (either parental or transduced), while modest reductions in red blood cells and platelets were observed in recipients of contaminated grafts. Significantly, in spite of the 10-fold increase in leukocyte numbers observed in mice receiving 10 5 leukemia cells, no increase in the proportion of myelomonocytic cells was noted in these recipients compared to mice receiving uncontaminated BM (Figure 8 ). Consistent with these data a reduced proportion of PB cells expressed or harbored the NGFr transgene (generally below 5%).
Discussion
The generation of new experimental models mimicking the relapse of patients transplanted with leukemia-contaminated grafts would facilitate the development of more efficient procedures of leukemia purging. The necessity of improving the procedures for eradicating leukemia cells from hematopoietic grafts has been mainly re-considered as a result of the observation that cancer cells, in particular leukemia cells, can contribute to the relapse of patients transplanted with BM autografts. 3, 22 In this work we describe a model in which Balb/c mice develop leukemia as a result of the transplantation of BM cells contaminated with limiting numbers of syngenic, genetically marked WEHI-3B cells. Other leukemia models based on the transplantation of genetically marked cells have already been developed. 4, 7 These studies revealed the advantages of using genetically marked cells to facilitate the identification of leukemia cells in a syngenic background, mainly in those cases in which no alternatives can be used for the identification of leukemia cells. This is particularly useful in the case of leukemia cells capable of undergoing partial or complete differentiation, given that the identification of these cells by in vitro culture techniques is not always possible.
In contrast to earlier studies in which leukemic cells were marked with genes conferring resistance to antibiotics 4 or encoding intracellular enzymes, 5, 6 in the proposed model in addition to the neo r gene -very useful for the generation of the transduced cell clones -the NGFr gene was used as a transmembrane cell marker. Earlier studies showed that this ectopic protein is not detectable in human hematopoietic cells 8, 18 and revealed the efficacy of using this transgene in experimental and clinical gene marking studies. 8, 16, 18, 23 Here we show that the anti-NGFr MoAb does not react with a number of mouse hematopoietic and non-hematopoietic tissues (see Figure 7) , nor with the parental leukemic WEHI-3B cells. As observed in other studies involving the gene marking of leukemia cells, 4, 5 no changes in the in vitro and in vivo properties of the transduced clones have been observed in Leukemia WEHI-3B/NGFr cells. This observation is also consistent with studies in which no apparent changes in the behavior of NGFr-transduced human hematopoietic cells are observed following their transplantation into NOD/SCID mice. 17 Because of the low background signals and the high expression of the NGFr in transduced cells, WEHI-3B/NGFr cells were easily identified by flow cytometry both in leukemia-contaminated grafts and in the organs of transplanted recipients. This allowed the rapid and accurate quantification of the degree of leukemia contamination in BM grafts (see Figure 5) , something which was not evident in the case of procedures based on the reaction of chromogenic or fluorescent substrates. The observation that the lower detection limit is well below 5% of leukemia cells in BM is of particular relevance, given that this constitutes the clinical criteria to define the complete remission of a leukemic patient.
By means of the transplantation of syngenic BM cells contaminated with increasing numbers of WEHI-3B/NGFr cells ( Figure 6 ), we showed that the survival rate of recipients is dependent on the number of inoculated leukemia cells, provided that a threshold number of WEHI-3B cells above 100 cells per recipient is transplanted. By reducing the number of transplanted BM cells by 20 times we observed that no changes in the shape of the survival curves are produced. This clearly indicates that the rate of leukemia incidence in recipients depends on the total number of inoculated leukemic cells, rather than on the proportion of WEHI-3B/NGFr cells in the graft; something to be considered when using this model in graft purging protocols.
As shown in Figure 7 , an evident dissemination of leukemia cells in the BM and liver of recipients transplanted with contaminated grafts was deduced from the analysis of the NGFr marker. However, as previously observed in non-conditioned mice inoculated with other models of transduced WEHI-3B cells, 5 only a modest contribution of genetically marked leukemia cells was seen in PB. This observation is consistent with data obtained 20 days after the transplantation of grafts contaminated with graded numbers of leukemia cells. In these experiments the number of PB leukocytes was dependent on the total number of infused leukemia cells. However, no evident changes in the proportion of myelomonocytic cells were observed in the different recipient groups (see Figure 8) , suggesting an indirect influence of leukemia dissemination on the PB counts. Whether increases of PB leukocytes in these leukemic mice are a consequence of the hematopoietic stimulation, mobilization or simply displacement of these cells by the leukemia cells is unknown. Nevertheless, the generalized increase of PB leukocytes in mice transplanted with WEHI-3B-contaminated grafts may well result as a consequence of the hematopoietic stimulatory effect mediated by the growth factors that can be secreted by WEHI-3B cells, including IL-3, 24 M-CSF, 25 IL-1␣, IL-1␤ and leukemia inhibitory factor. 26 Taken together, the transplantation of syngenic BM grafts contaminated with NGFr-WEHI-3B cells constitutes an improved experimental model mimicking the relapse of patients transplanted with autografts contaminated with myelomonocytic leukemia cells. On the basis of the reproducible in vivo effects produced as a result of the WEHI-3B/NGFr-8 graft contamination and considering the rapid and accurate determination of the leukemia cells using the NGFr marker, this model would facilitate the development of more efficient procedures of leukemia graft purging.
